Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Eosinophilic Asthma
Agamemnon Bakakos, Stelios Loukides, Petros Bakakos
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2670-2670
Open Access | Times Cited: 31
Metabo-Endotypes of Asthma Reveal Differences in Lung Function: Discovery and Validation in Two TOPMed Cohorts
Rachel S. Kelly, Kevin Mendez, Mengna Huang, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 205, Iss. 3, pp. 288-299
Open Access | Times Cited: 26
Global Burden of Asthma, and Its Impact on Specific Subgroups: Nasal Polyps, Allergic Rhinitis, Severe Asthma, Eosinophilic Asthma
Adrian Paul J. Rabe, Wei Jie Loke, Khushboo Gurjar, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1097-1113
Open Access | Times Cited: 10
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
(2024)
Open Access | Times Cited: 3
Advancements in biologic therapy in eosinophilic asthma
Rini Patadia, Thomas B. Casale, John R. Fowler, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 251-261
Closed Access | Times Cited: 3
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
Agamemnon Bakakos, Νikoletta Ρovina, Petros Bakakos
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3969-3969
Open Access | Times Cited: 21
Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)
Ariadna Petronela Fildan, Ruxandra Râjnoveanu, R.-E. CÎRJALIU, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 21
Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, et al.
Life Sciences (2021) Vol. 267, pp. 118973-118973
Open Access | Times Cited: 20
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control
Bradley E. Chipps, Robert S. Zeiger, David A. Beuther, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 4, pp. 436-443.e1
Open Access | Times Cited: 8
Dexamethasone protects against Aspergillus fumigatus-induced severe asthma via modulating pulmonary immunometabolism
Phyllis X.L. Gan, Wupeng Liao, Hui Fang Lim, et al.
Pharmacological Research (2023) Vol. 196, pp. 106929-106929
Open Access | Times Cited: 8
<p>Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights</p>
Francesco Menzella, Patrizia Ruggiero, Giulia Ghidoni, et al.
Journal of Asthma and Allergy (2020) Vol. Volume 13, pp. 301-313
Open Access | Times Cited: 23
Risk factors for severe adult-onset asthma: a multi-factor approach
Sanna Toppila‐Salmi, Riikka Lemmetyinen, Sébastien Chanoine, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study
Paolo Cameli, Maria Aliani, Elena Altieri, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 273-290
Open Access | Times Cited: 2
Chemical therapies, immunotherapy, and new treatment strategies for allergic asthma
Avik Sarkar, Sahithi Reddy Narala, Kalpana Panati, et al.
Elsevier eBooks (2024), pp. 117-166
Closed Access | Times Cited: 2
Progesterone modulates the immune microenvironment to suppress ovalbumin-induced airway inflammation by inhibiting NETosis
Lin Wang, Fengying Huang, Shu-Zhen Dai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Biologics in severe asthma: the overlap endotype - opportunities and challenges
Agamemnon Bakakos, Stelios Loukides, Omar S. Usmani, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 12, pp. 1427-1434
Closed Access | Times Cited: 20
The Nose as a Route for Therapy: Part 1. Pharmacotherapy
Cemal Cingi, Nuray Bayar Muluk, Dimitrios Mitsias, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 17
Epithelial Autoantigen-Specific IgG Antibody Enhances Eosinophil Extracellular Trap Formation in Severe Asthma
Dong-Hyun Lee, Jae-Hyuk Jang, Soyoon Sim, et al.
Allergy Asthma and Immunology Research (2022) Vol. 14, Iss. 5, pp. 479-479
Open Access | Times Cited: 12
Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update
Garry M. Walsh
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 10, pp. 1237-1244
Closed Access | Times Cited: 15
Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases
Eva M. Sturm, Eva Knuplez, Gunther Marsche
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4377-4377
Open Access | Times Cited: 14
Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases
Yinghan Chan, Sachin Kumar Singh, Monica Gulati, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103541-103541
Open Access | Times Cited: 9
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective
Xiao Xu, Caroline Schaefer, Ágota Szende, et al.
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 11, pp. 1193-1204
Open Access | Times Cited: 5
The immunomodulatory potentials of interleukin‐27 in airway allergies
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 13
Asthmatic Eosinophils Promote Contractility and Migration of Airway Smooth Muscle Cells and Pulmonary Fibroblasts In Vitro
Ieva Janulaitytė, Andrius Januškevičius, Virginija Kalinauskaitė-Žukauskė, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1389-1389
Open Access | Times Cited: 12
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Francisco Javier González‐Barcala, Xavier Muñoz, Esther Mariscal, et al.
Journal of Medical Economics (2021) Vol. 24, Iss. 1, pp. 874-882
Open Access | Times Cited: 12

Scroll to top